Organisation
Located
at two CEA sites (Saclay and Marcoule), the Department of Medicines and
Technologies for Health (DMTS) - part of the Frédéric Joliot Institute for Life
Sciences and directed by Stéphanie Simon - is a joint research unit (Unité
Mixte de Recherche) involving the CEA, the University of Paris-Saclay, and INRAe.
The DMTS conducts research in the field of molecular innovation for therapeutic
and in vitro diagnostic purposes, organized around three core areas:
from
the design of chemical tools for biology and small bioactive molecules to their
functional evaluation,
from
molecular engineering of proteins to their therapeutic and diagnostic
applications, and,
from
discovery of biomarkers to diagnostic tests.
These
activities draw on unique expertise in organic chemistry (notably bioorthogonal
chemistry), analytical chemistry (particularly mass spectrometry), isotopic
labeling (both radioactive and non-radioactive) and associated imaging
techniques, molecular engineering and immunogenicity of proteins,
immunoanalysis, cellular engineering, and preclinical evaluation models. A key
defining feature of the department is its translational focus, evidenced by the
creation of numerous spin-off companies designed to leverage patents for
potential drug candidates, as well as a joint laboratory with an in vitro
diagnostics firm, which helps accelerate the market launch of rapid diagnostic
tests. Finally, the DMTS is a major contributor to the interministerial R&D
program on CBRNE (Chemical, Biological, Radiological, Nuclear, and Explosive)
threats - a program entrusted to the CEA - which aims to develop preventive and
response measures against such hazards. In this capacity, the department
carries out work in the areas of detection, in vitro diagnostics, and
the development of medical countermeasures against chemical and biological
threat agents.
The department is organized into three units:
Exceptional facilities and platforms
To carry out their activities, researchers of Medicines and Healthcare Technologies Department have access to several research platforms, two of which certified
IBiSA, within the Frédéric Joliot Institute for Life Sciences: